KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EPS (Weighted Average and Diluted) (2020 - 2025)

Twist Bioscience (TWST) has disclosed EPS (Weighted Average and Diluted) for 6 consecutive years, with -$0.5 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 5.66% to -$0.5 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.28 through Dec 2025, up 62.13% year-over-year, with the annual reading at -$1.3 for FY2025, 63.89% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.5 at Twist Bioscience, down from -$0.45 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $0.33 in Q2 2025, with the low at -$1.47 in Q2 2024.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$0.77, with a median of -$0.8 recorded in 2023.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 45.54% in 2024, then skyrocketed 122.45% in 2025.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$0.91 in 2021, then increased by 18.68% to -$0.74 in 2022, then decreased by 1.35% to -$0.75 in 2023, then increased by 29.33% to -$0.53 in 2024, then increased by 5.66% to -$0.5 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.5, -$0.45, and $0.33 for Q4 2025, Q3 2025, and Q2 2025 respectively.